| # | Title | Journal | Year | Citations |
|---|
| 1 | The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP | Blood | 2007 | 1,193 |
| 2 | Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT | Journal of Clinical Oncology | 2008 | 460 |
| 3 | Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity | Blood | 2015 | 445 |
| 4 | The impact of new chemotherapeutic and hormone agents on survival in a population‐based cohort of women with metastatic breast cancer | Cancer | 2007 | 399 |
| 5 | Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma | Journal of Clinical Oncology | 2008 | 333 |
| 6 | Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification | Annals of Oncology | 2004 | 314 |
| 7 | Pathogenesis of follicular lymphoma | Journal of Clinical Investigation | 2012 | 264 |
| 8 | Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers | Journal of Clinical Oncology | 2008 | 260 |
| 9 | PD-L1 is highly expressed in Enzalutamide resistant prostate cancer | Oncotarget | 2015 | 227 |
| 10 | The biology and management of systemic anaplastic large cell lymphoma | Blood | 2015 | 157 |
| 11 | Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18) | Genes Chromosomes and Cancer | 2001 | 142 |
| 12 | The description of chemotherapy delivery: options and pitfalls | Seminars in Oncology | 1987 | 133 |
| 13 | Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub | Blood Advances | 2020 | 124 |
| 14 | Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer | Supportive Care in Cancer | 2011 | 123 |
| 15 | Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial | The Lancet Gastroenterology and Hepatology | 2018 | 121 |
| 16 | Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer | Cancer | 2015 | 118 |
| 17 | Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas | Genes Chromosomes and Cancer | 2004 | 114 |
| 18 | Limited-stage mantle-cell lymphoma | Annals of Oncology | 2003 | 98 |
| 19 | C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer | Cancer | 2008 | 98 |
| 20 | Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies | Lancet Haematology,the | 2018 | 97 |
| 21 | Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer | Cancer Medicine | 2015 | 94 |
| 22 | Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer | Cancer | 2008 | 91 |
| 23 | Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen | Annals of Oncology | 2007 | 90 |
| 24 | Mantle cell lymphoma in the ocular adnexal region | Ophthalmology | 2005 | 89 |
| 25 | Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel | Journal of Vascular and Interventional Radiology | 2016 | 87 |
| 26 | Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review | BMC Cancer | 2020 | 86 |
| 27 | Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review | Cancer and Metastasis Reviews | 2016 | 82 |
| 28 | Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma | Blood | 2019 | 77 |
| 29 | Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices | Journal of Clinical Oncology | 2022 | 77 |
| 30 | NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents | Annals of Oncology | 2020 | 75 |
| 31 | Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities | Oncologist | 2011 | 74 |
| 32 | Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus | Cancer Treatment Reviews | 2016 | 74 |
| 33 | Selective Destruction of Gliomas in Immunocompetent Rats by Thymidine Kinase-Defective Herpes Simplex Virus Type 1 | Journal of the National Cancer Institute | 1994 | 71 |
| 34 | Outcome prediction by extranodal involvement, IPI, R‐IPI, and NCCN‐IPI in the PET/CT and rituximab era: A Danish–Canadian study of 443 patients with diffuse‐large B‐cell lymphoma | American Journal of Hematology | 2015 | 71 |
| 35 | Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial | Lancet Oncology, The | 2017 | 67 |
| 36 | Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity | Clinical Cancer Research | 2017 | 65 |
| 37 | The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy | European Journal of Cancer | 2017 | 65 |
| 38 | Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica | 2010 | 63 |
| 39 | Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX | American Journal of Clinical Oncology: Cancer Clinical Trials | 2017 | 61 |
| 40 | Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases | Leukemia and Lymphoma | 2004 | 56 |
| 41 | Hodgkin's Lymphoma in Adolescents | Journal of Clinical Oncology | 2006 | 55 |
| 42 | Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414) | Journal of Thoracic Oncology | 2012 | 54 |
| 43 | Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer | Clinical Cancer Research | 2009 | 51 |
| 44 | Bone Marrow Involvement in T-Cell–Rich B-Cell Lymphoma | American Journal of Clinical Pathology | 1997 | 50 |
| 45 | Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection | Cancer Chemotherapy and Pharmacology | 1998 | 48 |
| 46 | Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma | Hematology American Society of Hematology Education Program | 2012 | 48 |
| 47 | Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes | Nature Communications | 2022 | 46 |
| 48 | Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma | Hematology American Society of Hematology Education Program | 2012 | 44 |
| 49 | The Combination of Cyproterone Acetate and Low Dose Diethylstilbestrol in the Treatment of Advanced Prostatic Carcinoma | Journal of Urology | 1988 | 43 |
| 50 | Association Between Palliative Resection of the Primary Tumor and Overall Survival in a Population-Based Cohort of Metastatic Colorectal Cancer Patients | Annals of Surgical Oncology | 2014 | 42 |
